A Streamlined Approach to Basophil Activation Testing for Longitudinal Characterization of Toddlers with Peanut Allergy During a Multi-Site Phase 3 Double-Blind Placebo-Controlled Trial of Epicutaneous Immunotherapy (EPIT) - 05/02/24
Doi : 10.1016/j.jaci.2023.11.874
Alexander Grishin, PhD 1, Rihane Arif-Lusson 2, Penelope Bourgoin 2, Katie Matthews, PhD 3, Dianne Campbell, MBBS FRACP PhD 4, Henry Bahnson 3, Jean-Marc Busnel 5, Hugh Sampson, MD 6
1 Mount Sanai School Of Medicine
2 Beckman Coulter Life Sciences, Marseille, France
3 DBV Technologies
4 NSW Health, Allergy and Immunology
5 Beckman Coulter Life Sciences
6 Icahn School of Medicine at Mount Sinai
L19
El texto completo de este artículo está disponible en PDF.Esquema
© 2023
Vol 153 - N° 2S
P. AB366 - février 2024 Regresar al número
Artículo precedente
- Barzolvolimab Significantly Decreases Chronic Spontaneous Urticaria Disease Activity and is Well Tolerated: Top Line Results from a Phase 2 Trial
- Marcus Maurer, Iwona Kobielusz-Gembala, Essack Mitha, Jeffrey Leflein, Maia Gotua, Bartlowmiej Kwiek, Martin Metz, Michael Yellin, Cherie Taglienti, Rick Ma, Diego Alvarado, Elsa Paradise, Jonathan Bernstein
- Indoor Allergen Exposure and Its Influence on Upper Respiratory Infections and Pulmonary Outcomes among Children with Asthma
- Darlene Bhavnani, Sylvie Beaudenon-Huibregtse, Meghan Davis, Meredith McCormack, Corinne Keet, Susan Balcer-Whaley, Michelle Newman, Elizabeth Matsui
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?